Reportable Segment — Income taxes (Note 14)

Business Segments · Income taxes (Note 14)

Eli Lilly Reportable Segment — Income taxes (Note 14) increased by 47.9% to $1.65B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 166.9%, from $618.10M to $1.65B. Over 2 years (FY 2022 to FY 2024), Reportable Segment — Income taxes (Note 14) shows an upward trend with a 92.9% CAGR.

Analysis

StatementSegment
First reportedQ1 2022
Last reportedQ3 2025
Rolls up toIncome Tax
Metric ID: lly_segment_reportable_segment_income_taxes_note_14

Historical Data

15 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$140.40M$140.40M$140.40M$140.40M$328.55M$328.55M$328.55M$328.55M$293.20M$550.20M$618.10M$628.90M$696.80M$1.12B$1.65B
QoQ Change—+0.0%+0.0%+0.0%+134.0%+0.0%+0.0%+0.0%-10.8%+87.7%+12.3%+1.7%+10.8%+60.1%+47.9%
YoY Change————+134.0%+134.0%+134.0%+134.0%-10.8%+67.5%+88.1%+91.4%+137.7%+102.8%+166.9%
Range$140.40M – $1.65B
CAGR+102.2%
Avg YoY Growth+107.2%
Median YoY Growth+134.0%
Current Streak6 quarters growth

Frequently Asked Questions

What is Eli Lilly's reportable segment — income taxes (note 14)?
Eli Lilly (LLY) reported reportable segment — income taxes (note 14) of $1.65B in Q3 2025.
How has Eli Lilly's reportable segment — income taxes (note 14) changed year-over-year?
Eli Lilly's reportable segment — income taxes (note 14) increased by 166.9% year-over-year, from $618.10M to $1.65B.
What is the long-term trend for Eli Lilly's reportable segment — income taxes (note 14)?
Over 2 years (2022 to 2024), Eli Lilly's reportable segment — income taxes (note 14) has grown at a 92.9% compound annual growth rate (CAGR), from $561.60M to $2.09B.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.

Eli Lilly (LLY) Reportable Segment — Income taxes (Note 14) — Quarterly & Annual | OpenCapital